Skip navigation

Docobo, a leading UK telehealth company which enables the remote monitoring of patients with long term health conditions such as asthma, COPD, heart disease and hypertension, is to extend its doc@HOME solution to enable patient interaction via mobile phones. The aim is to provide an unprecedented level of flexibility in disease management for patients through large and small healthcare organisations. It means that patients who lead active lives can monitor their condition whilst out and about.

Docobo’s widely used HealthHUB portable home monitor enables patients to record vital signs, symptoms, lifestyle and quality of life measures around the clock from any location. This information is then securely transferred to the doc@HOME clinical database that can be accessed by clinicians using a standard secure web browser, which provides a presentation of the patient’s health diary and alert indicators. The new mobile platform will allow a larger cohort of patients to monitor aspects of their health through their mobile phone as well as the HealthHUB, depending on their specific needs.

Doc@HOME is a fully versatile system that can be configured to meet the health needs of individual patients; empower patients to participate in their care delivery, support their carers and reduce the burden of care provision through particular information required by clinicians to deliver expert care on a patient by patient basis.

“Many patients who use the HealthHUB do so from the comfort and convenience of their home,” explains Adrian, Flowerday, Managing Director of Docobo. “Telehealth solutions enable patients to empower themselves in their own treatment which has other benefits such as cutting down on unnecessary visits to the GP or clinic.

“However, some of our patients, who either prefer to use their mobile phone, or are not symptomatic enough to need the rich functionality of the HealthHUB, can now benefit from the doc@HOME service. Many of them lead extremely active lives and the mobile phone is a simple, convenient and effective way of collecting essential data.”

As well as being convenient and easy to use, interactive and personalised software built into the mobile solution means that patients can receive immediate feedback from their clinician after data is entered.

For the clinician, it means that thousands of patients can be catered for without them having to spend their time visiting the GP’s surgery, clinic or hospital. Already valuable medical practitioners’ time has been saved by deploying doc@HOME in homes and clinics throughout the UK. Furthermore there have been reductions in out of hours calls and unnecessary hospital admissions.

The mobile solution is the latest development in Docobo’s long term strategy to deliver patient care in a variety of formats based on tried and tested technologies.
Ends

Editors Notes:

Media enquiries:

Glen Goldsmith
2thefore
Mobile: +44 (0)7812 766 338
Email: glen@2thefore.biz

About Docobo – www.docobo.co.uk

Docobo Ltd is a UK healthcare solutions provider, involved in the management and prevention of Long Term Conditions (LTCs, also known as chronic diseases). The company is at the forefront of the development of systems for the management of patients with Long Term Conditions in their own homes.

The company has developed a remote monitoring service for LTC’s, called doc@HOME®, and is developing a focused range of related services and products to expand its portfolio. This telehealth service offers care providers with an integrated low cost solution for the collection, management and analysis of essential patient related data, and permits efficient interaction between clinicians and patients at home.


This press release was distributed by ResponseSource Press Release Wire on behalf of 2thefore in the following categories: Children & Teenagers, Men's Interest, Health, Home & Garden, Women's Interest & Beauty, Consumer Technology, Business & Finance, Education & Human Resources, Medical & Pharmaceutical, Public Sector, Third Sector & Legal, Computing & Telecoms, for more information visit http://pressreleasewire.responsesource.com/about.